Markets to continue following the path of COVID recovery Cross-asset Strategy: Risk markets recovered from the technical sell-off, as we called for last week. COVID cases continue to decline (falling by ~28% in the US and ~13% globally over the past week), which we believe remains the main driver of risk markets, and this trend is likely to continue in…
J.P. Morgan MacroView Into Q3 2021 Quarter-End
A financial market resource for the every-day investor and trader.
-
History of Markets Is On Full Display and Trending…
Seth Golden, , Research Reports, 0
The S&P 500 (SPX) flip flopped this week, but spent the last few days hovering around a 40-point range....
-
The Techs Say Lower From Here
Edward Cordoba, , Research Reports, 0
As we enter the corrective phase of the market moves, we seek the guidance of technical analysis to provide...
-
VIX Trading: Even The Pros Get It Wrong
Seth Golden, , Research Reports, 0
It can sometimes be a little confusing to the average investor when the media and financial market communities throw...
-
Will Overbought Conditions Offer a 5% Sale for S&P 500?
Seth Golden, , Research Reports, 0
You see? It’s not all rainbows and unicorns in the markets as they say and last week wasn’t even...
-
A Summer Rally and Summer Lull
Seth Golden, , Research Reports, 0
Although the S&P 500 (SPX) would achieve a new, intraday all-time high this past week (Friday), it would fail...
-
Lead Biotech Analysts Updates Vaccine Forecast
Seth Golden, , Research Reports, 0
Pfizer has not yet accrued the32 COVID infections for its 1st interim analysis: The fact that Pfizer’s first interim...
-
4 Trading Days Left in 2020
Seth Golden, , Research Reports, 0
Please click the following link to be directed to our latest YouTube video where we discuss our concluding thoughts...
-
Artisan Parnters: Investing in Health Care: Beyond the Buzzwords
Seth Golden, , Research Reports, 0
Some of the 21st century’s biggest breakthroughs are happening in health care, transforming the way we diagnose, treat and...
Recent Articles
Featured Products
- JPM Market Recap $0.00
- JPM Research Note $0.00
- JP Morgan Market Volatility Report $0.00